Vernalis (VER)

 

VER Share PerformanceMore

52 week high33.500 20/02/17
52 week low6.100 14/02/18
52 week change -25.400 (-79.38%)
4 week volume9,328,409 25/01/18
price6.600
price date1519136933
close6.300

Latest NewsMore

Price Monitoring Extension

RNS Number: 3715E Vernalis PLC 08 February 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occu...

Total Voting Rights

RNS Number: 2499A Vernalis PLC 29 December 2017 TOTAL VOTING RIGHTS VERNALIS PLC (the "Company") 29 December 2017 Vernalis plc (LSE: VER) announces that the Company's total issued share capital at the date of this announcement is 526,819,624 ordinary shares of 1p each, with one voting right per share. There are no shares held in treasury. The to...

Second Price Monitoring Extn

RNS Number: 3917A Vernalis PLC 27 December 2017 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percen...

Price Monitoring Extension

RNS Number: 3909A Vernalis PLC 27 December 2017 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occ...

Vernalis Results of Annual General Meeting

RNS Number: 2977Z Vernalis PLC 14 December 2017 14 December 2017 LSE: VER Vernalis Results of Annual General Meeting Resolutions Vernalis plc (LSE: VER) announces that all resolutions proposed to shareholders at its Annual General Meeting held today were duly passed. All resolutions were approved on a show of hands. The number of proxy votes received...

Vernalis reports steady growth in Tuzistra XR

Prescriptions of Vernalis' cough cold syrup Tuzistra XR continue to grow steadily, up 85% in the 22 weeks to 1 December. H...

AGM Statement

RNS Number: 2975Z Vernalis PLC 14 December 2017 14 December 2017 LSE: VER AGM Statement Tuzistra XR prescriptions continue to grow steadily, despite a reduction in narcotic prescribing Vernalis plc ("Vernalis" or the "Company") provides an update ahead of its Annual General Meeting ("AGM") being held today at 10.30 am at the offices of Covington & B...

Vernalis partners with Daiichi Sankyo

Vernalis has entered into a drug discovery collaboration with Daiichi Sankyo Company which will utilizing Vernalis' frag...

Fundamental DataMore

EPS-4.1
Dividend yield0 %

Latest discussion posts More

  • Closing my long term short here

    It's been a long one ( since mid Aug 2016 ) now . Whilst trend wise it's obviously only going one way I think we may find a bottom here . So my risk reward view of ...
    25-Oct-2017
    onedb1
  • Re: Perfect short this one !

    Remember my post back in April ? Not many here since . Chart don't lie , it didn't then it isn't now . Though it may be basing . Or about to . In other words we ...
    17-Aug-2017
    onedb1
  • Bearish despite RNS

    Recent RNS from Vernalis: "Total revenues are expected to be ahead of current market expectations, principally as a result of larger than expected research collaboration ...
    2-Aug-2017
    optimusanimus

Users' HoldingsMore

Users who hold Vernalis also hold..

Codes & Symbols

ISINGB00B3Y5L754
SymbolsVER, LSE:VER, VER.L, VER:LN, LON:VER, XLON:VER

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account